Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction

Haematologica

Volumn 92, Issue 7, 2007, Pages 881-888

  Prevosto, Claudia ^a   Zancolli, Marta ^b   Canevali, Paolo ^a   Zocchi, Maria Raffaella ^b   Poggi, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Lymphocyte triggering; Mesenchymal stem cells; Regulatory CD4+ T cells; Regulatory CD8+ T cells

Indexed keywords

ALLOANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; PHYTOHEMAGGLUTININ; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ACUTE LEUKEMIA; ARTICLE; BONE MARROW; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CHEMOTHERAPY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA REMISSION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; RECEPTOR GENE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; ACUTE DISEASE; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; LEUKEMIA; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; PATHOLOGY;

ACUTE DISEASE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; HUMANS; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; MESENCHYMAL STEM CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 34548739534     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11240     Document Type: Article

References (44)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
2. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximaze the yelds of early progenitors and evaluate their quality. Stem Cells 2002;20:530-41.
3. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, et al. Non-hematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004;104:3581-7.
4. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone marrow Transplant 1995; 16:557-64.
5. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al.Isolated allogeneic bone-marrow derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Sci USA Acad 2002;99:8932-7.
6. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-70.
7. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression or allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-97.
8. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Stucchi C, Cleris L. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99:3838-43.
9. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5:485-9.
10. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57:11-20.
11. Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003; 171:3426-34.
12. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102:3837-44.
13. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness. Blood 2005; 105:2214-9.
14. Meisel R, Zibert A, Laryea M, Gobel U, Daubener U, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-21.
15. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22.
16. Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R at al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed cell death 1 pathway. Eur J Immunol 2005;35:1482-90.
17. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hussan M, Uzunel M et al. Treatment of severe acute graft-versus host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363:1439-41.
18. Mahic M, Yaqub S, Johansson CC, Tasken K, Aandahl EM. Foxp3+ CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 2006; 177:246-54.
19. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance Cell 2000; 101: 455-8.
20. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-, in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166:7282-9.
21. Strom TB, Carpenter CB. Prostaglandin as an effective antirejection therapy in rat renal allograft recipient. Transplantation 1983; 35:279-81.
22. Baratelli F, Lin Y, Zhu L, Yang SC, Henze-Vourc'h N, Zeng G et al. Prostaglandin E2 induces Foxp3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol 2005; 175:1483-90.
23. Rifa'I M, Kawamoto Y, Nakashima I, Suzuki H. Essential role of CD8+ CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004; 200:1123-34.
24. Xystrakis E, Dejean AS, Bernard I, Druet P, Liblau R, Gonzales-Dunia D, et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 2004; 104:3294-301.
25. Zheng SG, Wang JH, Koss MN, Quismorio F Jr, Gray JD, Horwitz DA. CD4+ and CD8+ regulatory T cells generated ex-vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus host disease with lupus-like syndrome. J Immunol 2004; 172:1531-9.
26. Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P et al. Plasmocitoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005; 65:5020-26.
27. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212: 28-50.
28. Groux H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003; 15:8S-12S.
29. Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, et al. Phenotype, localization and mechanism or suppression of CD4+ CD25+ regulatory thymocytes. J Exp Med 2002;196:379-87.
30. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005;6:1142-51.
31. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389-400.
32. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-62.
33. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6:338-43.
34. Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation or CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005; 90:516-25.
35. Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N et al. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α. J Exp Med 1991;174:1393-8.
36. Poggi A, Tomasello E, Revello V, Nanni L, Costa P, Moretta L. p40 regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Int Immunol 1997;9:1271-9.
37. Poggi A, Prevosto C, Massaro AM, Negrini S, Urbani S, Pierri I, et al. Interaction between human natural killer cells and bone marrow stromal cells induces NK cell triggering. Role of NKp30 and NKG2D receptors. J Immunol 2005;175:6352-60.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DDCT) method. Methods 2001; 25:402-8.
39. Krampera M, Cosmi L, Angeli R, Pasini A, Lotta F, Andreini A et al. Role of IFN-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006;24:386-98.
40. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev 2006;6:295-307.
41. Poggi A, Massaro AM, Negrini S, Pierri I, Balocco M, Michelis G, et al. Evidence for killing of mesenchymal stem cells (MSC) by autologous natural killer lymphocytes. Blood (ASH Annual Meeting Abstracts), Nov 2004; 104:1290.
42. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107:1484-90.
43. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006; 24:74-85.
44. Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB. Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 2006;177:2765-9.